Results 121 to 130 of about 754 (147)

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.

open access: yesBlood
Sharman JP   +26 more
europepmc   +1 more source

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. [PDF]

open access: yesBlood Adv
Hampel PJ   +15 more
europepmc   +1 more source

Criminalidad y globalización

open access: yesBoletín Mexicano de Derecho Comparado, 2006
Luigi Ferrajoli
doaj  

Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.

open access: yesBlood
Brown JR   +25 more
europepmc   +1 more source

Ferrajoli, Luigi, Razones jurídicas del pacifismo

open access: yesCuestiones Constitucionales Revista Mexicana de Derecho Constitucional, 2005
openaire   +2 more sources

Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma. [PDF]

open access: yesCancers (Basel)
Isbell LK   +12 more
europepmc   +1 more source

Ferrajoli successore di Kelsen o Kelsen precursore di Ferrajoli?

Ragion pratica, 2017
This paper, originally a presentation of Luigi Ferrajoli’s La logica del diritto. Dieci aporie nell’opera di Hans Kelsen (2016), compares the jurisprudences of the two authors, by problematizing their disagreements on the relationship between existence and validity of norms.
openaire   +2 more sources

Ferrajoli on Rights

International Journal for the Semiotics of Law, 2001
The author considers the distinction drawn by Ferrajoli betweenrights and their guarantees to be an important acquisition forpost-Kelsenian legal theory, but criticises the distinction drawn between fundamental rights and patrimonial rights, in particular contesting the hypothesis that non-disposability/inalienabilityis a characteristic of fundamental ...
openaire   +1 more source

Home - About - Disclaimer - Privacy